Gujarat Alkalies Q2 results and new auditor appointment

8 Nov 2025 · 16:05 ISTafter close1 source ↓written by the desknot a recommendation

Gujarat Alkalies & Chemicals reported Q2 revenue of ₹1,907.32 cr for the quarter ending 30 Sept 2025. The company also made a provision of ₹1,549.24 cr for goods damaged in a fire at a contract manufacturer's facility. Additionally, it appointed M/s Talati Talati LLP as internal auditors for a two-year term starting July 2026.

Not investment advice. For informational purposes only.

OI Charts is not a SEBI-registered investment adviser or research analyst. This bulletin was written by the OI Charts desk from the public sources listed here. It is commentary on market conditions, not a basis for any investment decision and not a recommendation to buy or sell any security. Prices as of 8 Nov 2025, 16:05 IST.

Sourcesnews.google.com

GACL
Chemicals

10 FebGACL approves capex for biofuel and coal boiler projectsMediumGujarat Alkalies and Chemicals Limited reported Q3 revenue of ₹1,008 cr, up from ₹1,001 cr last year, with EBITDA rising 19% to ₹135 cr. The board approved major capex for biofuel and coal boiler projects, enhancing sustainability and operational efficiency.
9 FebGACL approves ₹1,000 cr Capex for capacity expansionHighGujarat Alkalies and Chemicals Limited approved a capital expenditure plan exceeding ₹1,000 crore for capacity expansion, including a new phosphoric acid plant and biofuel boilers. The project is expected to generate additional annual revenues of ₹350 crore.
1 OctGanjam attracts ₹1 lakh crore investment in green energyHighGanjam is rapidly becoming a major industrial hub in Odisha, attracting over ₹1 lakh crore in investments, particularly in green energy and chemicals. The Gopalpur Industrial Park has secured ₹65,400 crore in commitments, enhancing its industrial significance in eastern India.
30 SeptGanesh Benzoplast sells logistics business for ₹1,154 croreHighGanesh Benzoplast signed an agreement to sell its logistics businesses for ₹1,154 crore to KKR-backed Cisternina Logistics. This divestment will allow the company to focus on its specialty chemicals sector, with the deal pending necessary approvals.
29 SeptAnupam Rasayan completes Bliss GVS Pharma acquisitionHighAnupam Rasayan India has acquired a 48.2% stake in Bliss GVS Pharma at ₹299 per share, funded by a ₹300 crore loan and ₹1,450 crore from investors. This strategic move enhances its portfolio in pharmaceuticals.
22 SeptIOL Chemicals plans ₹500 Cr investment for growthMediumIOL Chemicals announced a ₹500 crore investment in Ibuprofen expansion, CDMO formulations, and specialty chemicals. These projects aim to enhance operations and could drive 30% revenue growth, reflecting rising demand in the chemicals and pharmaceuticals sector.

Gujarat Alkalies Q2 results and new auditor appointment

Related